Chartwell Investment Partners LLC Has $21.62 Million Position in Danaher Co. (NYSE:DHR)

Chartwell Investment Partners LLC cut its stake in Danaher Co. (NYSE:DHR - Free Report) by 6.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,777 shares of the conglomerate's stock after selling 5,352 shares during the period. Danaher accounts for 0.7% of Chartwell Investment Partners LLC's investment portfolio, making the stock its 19th largest holding. Chartwell Investment Partners LLC's holdings in Danaher were worth $21,623,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. bought a new stake in shares of Danaher during the second quarter worth $25,000. nVerses Capital LLC purchased a new position in Danaher during the second quarter worth about $25,000. MFA Wealth Advisors LLC purchased a new position in Danaher during the 2nd quarter worth $51,000. Financial Connections Group Inc. acquired a new position in Danaher in the 2nd quarter valued at $51,000. Finally, Western Pacific Wealth Management LP purchased a new position in Danaher in the first quarter worth $55,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Down 1.0 %

NYSE DHR traded down $2.49 during trading on Monday, reaching $242.90. 1,539,051 shares of the stock traded hands, compared to its average volume of 2,738,561. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm has a market cap of $175.44 billion, a price-to-earnings ratio of 47.31, a price-to-earnings-growth ratio of 4.51 and a beta of 0.85. The stock's 50-day moving average price is $264.89 and its 200 day moving average price is $260.84. Danaher Co. has a fifty-two week low of $193.75 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the company earned $2.02 EPS. The firm's revenue was up 3.1% compared to the same quarter last year. Analysts predict that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher's payout ratio is currently 20.61%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. The Goldman Sachs Group upped their target price on Danaher from $225.00 to $250.00 and gave the company a "neutral" rating in a research note on Wednesday, July 24th. KeyCorp upped their target price on Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a report on Wednesday, October 23rd. Stephens reiterated an "overweight" rating and issued a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. StockNews.com raised Danaher from a "hold" rating to a "buy" rating in a report on Wednesday, November 6th. Finally, TD Cowen lifted their price target on shares of Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $287.16.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the business's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.